Amanta Healthcare Limited — PPTs, 19-05-2026: Investor Presentation

Here's a summary of Amanta Healthcare Limited's investor presentation:

**1. Business Performance:**

Amanta Healthcare reported a 5% YoY increase in FY26 revenue to INR 288 Cr. Q4FY26 revenue also saw a 7% YoY growth, reaching INR 77 Cr. Profitability for FY26 surged by 42% YoY to INR 15 Cr, driven by a decrease in finance costs. EBITDA margins remained strong at 22% for FY26.

**2. Growth Drivers or Strategy:**

The company is focusing on expanding its market depth by targeting complex dosages and niche molecules. Capacity expansion for high-margin SteriPort and SVP products is underway. They are also implementing a 10.8 MW solar captive power plant, expected to save INR 9 Cr annually and improve EBITDA margins.

**3. Recent Developments:**

The presentation highlights ongoing capacity expansion for SteriPort and SVP, with commissioning targeted for Q1FY27 and Q4FY27 respectively.

**4. Key Financial Metrics:**

* FY26 Revenue: INR 288 Cr (vs. INR 275 Cr in FY25)

* FY26 PAT: INR 15 Cr (vs. INR 11 Cr in FY25)

* FY26 EBITDA: INR 63 Cr (vs. INR 61 Cr in FY25)

* Debt to Equity Ratio improved to 1.06x in FY26 from 1.24x in FY25.

**5. Management Commentary / Outlook:**

Amanta Healthcare anticipates revenue CAGR of over 20% and EBITDA margins of over 25% in the next two years, supported by its growth levers. The company is also increasing its focus on exports to regulated markets, aiming for higher margins.